Patents by Inventor Dario N. Carrara

Dario N. Carrara has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Diclofenac formulations
    Patent number: 10117829
    Abstract: The subject invention provides improved diclofenac gel formulations.
    Type: Grant
    Filed: May 18, 2018
    Date of Patent: November 6, 2018
    Assignee: Ferring B.V.
    Inventors: Arnaud Grenier, Dario N. Carrara
  • DICLOFENAC FORMULATIONS
    Publication number: 20180263897
    Abstract: The subject invention provides improved diclofenac gel formulations.
    Type: Application
    Filed: May 18, 2018
    Publication date: September 20, 2018
    Inventors: Arnaud Grenier, Dario N. Carrara
  • Diclofenac formulations
    Patent number: 9999590
    Abstract: The subject invention provides improved diclofenac gel formulations.
    Type: Grant
    Filed: July 4, 2013
    Date of Patent: June 19, 2018
    Assignee: Ferring B.V.
    Inventors: Arnaud Grenier, Dario N. Carrara
  • DICLOFENAC FORMULATIONS
    Publication number: 20150297507
    Abstract: The subject invention provides improved diclofenac gel formulations.
    Type: Application
    Filed: July 4, 2013
    Publication date: October 22, 2015
    Applicant: FERRING B.V.
    Inventors: Arnaud Grenier, Dario N. Carrara
  • TESTOSTERONE FORMULATIONS
    Publication number: 20150110856
    Abstract: The subject invention provides improved testosterone gel formulations.
    Type: Application
    Filed: October 22, 2014
    Publication date: April 23, 2015
    Inventors: Arnaud Grenier, Dario N. Carrara
  • Testosterone formulations
    Patent number: 8895053
    Abstract: The subject invention provides improved testosterone gel formulations.
    Type: Grant
    Filed: January 18, 2012
    Date of Patent: November 25, 2014
    Assignee: Ferring B.V.
    Inventors: Arnaud Grenier, Dario N. Carrara
  • TESTOSTERONE FORMULATIONS
    Publication number: 20130295166
    Abstract: The subject invention provides improved testosterone gel formulations.
    Type: Application
    Filed: January 18, 2012
    Publication date: November 7, 2013
    Applicant: FERRING B.V.
    Inventors: Arnaud Grenier, Dario N. Carrara
  • Transdermal delivery system for estradiol and process for manufacturing said device
    Patent number: 5518734
    Abstract: The present invention relates to a transdermal delivery device for estradiol where the metabolic degradation of estradiol to estrone during permeation is inhibited by another substance in the transdermal delivery device. The transdermal device also includes a compound for enhancing the rate of estradiol permeation. The transdermal delivery device containing the inhibitor and enhancer can also be used to simultaneously deliver both estradiol and a progestin at therapeutic rates.
    Type: Grant
    Filed: March 2, 1993
    Date of Patent: May 21, 1996
    Assignee: Beta Pharmaceuticals Co.
    Inventors: Francisco J. Stefano, Jose A. Nowogrodski, Dario N. Carrara